Measuring cardiac output in children undergoing cardiac catheterization: comparison between the Fick method and PRAM (pressure recording analytical method)
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Alonso-Inigo, JM
- Fas, MJ
- Galvis, JM
- Llopis, JE
Grupos
Abstract
BackgroundPressure recording analytical method (PRAM) is a novel, arterial pulse contour method for measuring cardiac output (CO). Validation studies of PRAM in children are few, and have shown contradictory results. The aim of the study was to compare the MostCare((R))-PRAM vs the Fick method of cardiac output estimation (reference method). MethodsThis is a single-center, prospective observational study in 52 pediatric patients who underwent diagnostic right and left heart catheterization. Cardiac index (CI) measurements with the MostCare((R))-PRAM vs the Fick method were obtained under hemodynamically stable conditions. ResultsForty CI measurements were performed. The data showed good agreement between CIFick and CIPRAM: r(2) = 0.90 (P < 0.001), mean bias -0.075, limits of agreement from -0.56 to 0.41. The percentage error was 17%. Comparable results were obtained for patients <20 kg (r(2) = 0.87, P < 0.001), mean bias -0.135, limits of agreement from -0.35 to 0.62, percentage of error 17%. ConclusionsIn pediatric patients undergoing diagnostic right and left heart catheterization, the MostCare((R))-PRAM was shown to estimate CI with a good level of agreement with the Fick method measurements.
Datos de la publicación
- ISSN/ISSNe:
- 1155-5645, 1460-9592
- Tipo:
- Article
- Páginas:
- 1097-1105
- DOI:
- 10.1111/pan.12997
- PubMed:
- 27565740
- Factor de Impacto:
- 0,964 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
PEDIATRIC ANESTHESIA WILEY-BLACKWELL
Citas Recibidas en Web of Science: 14
Documentos
- No hay documentos
Filiaciones
Keywords
- cardiac output; pulse contour methods; pressure recording analytical method; Fick method; pediatric; congenital heart disease
Proyectos y Estudios Clínicos
ESTUDIO DE SEGUIMIENTO, MULTICÉNTRICO, ABIERTO, A LARGO PLAZO, PARA EVALUAR LA SEGURIDAD Y LA EFICACIA DE BRIVARACETAM COMO TRATAMIENTO ADYUVANTE EN PACIENTES PEDIÁTRICOS CON EPILEPSIA.
Investigador Principal: PATRICIA SMEYERS DURA
N01266 . 2012
ESTUDIO SIMPLE CIEGO, ALEATORIZADO, MULTICÉNTRICO, CON CONTROL ACTIVO PARA EVALUAR LA SEGURIDAD, TOLERABILIDAD, FARMACOCINÉTICA Y EFICACIA DE CEFTAZIDIMA Y AVIBACTAM CUANDO SE PROPORCIONAN CON METRONIDAZOL EN COMPARACIÓN CON MEROPENEM EN NIÑOS DE 3 MESES A MENOS DE 18 AÑOS DE EDAD CON INFECCIONES INTRAABDOMINALES COMPLICADAS (IIACS).
Investigador Principal: EMILIO MONTEAGUDO MONTESINOS
D4280C00015 . 2015
ESTUDIO FASE I-II DE VINBLASTINA EN COMBINACIÓN CON NILOTINIB EN NIÑOS, ADOLESCENTES, Y ADULTOS JÓVENES CON GLIOMA DE BAJO GRADO REFRACTARIO O RECURRENTE.
Investigador Principal: ADELA CAÑETE NIETO
IGR2012/1883 . 2015
Cita
Alonso JM,ESCRIBA FJ,CARRASCO JI,Fas MJ,ARGENTE P,Galvis JM,Llopis JE. Measuring cardiac output in children undergoing cardiac catheterization: comparison between the Fick method and PRAM (pressure recording analytical method). Pediatr. Anesth. 2016. 26. (11):p. 1097-1105. IF:2,254. (2).